Page last updated: 2024-12-06
flindersiamine
Description
flindersiamine: from Helietta parvifolia; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|
| Helietta | genus | [no description available] | Rutaceae | A plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH] |
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 68221 |
| CHEMBL ID | 503519 |
| CHEBI ID | 5093 |
| SCHEMBL ID | 7913645 |
| MeSH ID | M0059274 |
Synonyms (22)
| Synonym |
|---|
| 4,9-dimethoxy-1,3-dioxolo(4,5-g)furo(2,3-b)quinoline |
| brn 0289158 |
| nsc 284684 |
| 1,3-dioxolo(4,5-g)furo(2,3-b)quinoline, 4,9-dimethoxy- |
| ccris 3581 |
| nsc-284684 |
| 1,5-g]furo[2,3-b]quinoline, 4,9-dimethoxy- |
| flindersiamin |
| nsc284684 |
| flindersiamine |
| 522-06-5 |
| CHEMBL503519 |
| chebi:5093 , |
| 4-27-00-06802 (beilstein handbook reference) |
| 6q8rkp2039 , |
| unii-6q8rkp2039 |
| SCHEMBL7913645 |
| IMJCEVWDXKCHOI-UHFFFAOYSA-N |
| 1,3-dioxolo[4,5-g]furo[2,3-b]quinoline, 4,9-dimethoxy- |
| 4,9-dimethoxy[1,3]dioxolo[4,5-g]furo[2,3-b]quinoline # |
| DTXSID40200229 |
| Q27106652 |
Drug Classes (3)
| Class | Description |
|---|
| oxacycle | Any organic heterocyclic compound containing at least one ring oxygen atom. |
| organonitrogen heterocyclic compound | Any organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms. |
| organic heterotricyclic compound | An organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.87 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.66 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |